malondialdehyde has been researched along with ao 128 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, S; Ejiri, K; Fuke, S; Hata, Y; Ito, H; Kawai, Y; Kihara, H; Minagawa, T; Miyoshi, T; Nagano, T; Nakamura, K; Nakamura, Y; Namba, S; Nishii, N; Sakuragi, S; Takaishi, A; Toda, H; Yoshikawa, M | 1 |
1 trial(s) available for malondialdehyde and ao 128
| Article | Year |
|---|---|
Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failure.
Topics: Adiponectin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Diabetes Mellitus, Type 2; Glucose; Heart Failure; Humans; Inositol; Malondialdehyde; Sodium; Sorbitol | 2022 |